professionaladviser_logo

FOR SUSTAINABLE, PROFITABLE, CLIENT-FOCUSED ADVISER FIRMS

pin Sign in Join
pin
    • My account
    • Sign out
  • You are currently accessing Professional Adviser via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0) 1858 438800

    Email: [email protected]

    • Sign in
logo
  • logo

    Search Professional Adviser

  • News
  • More

    Choose from below

    • Features
    • Opinion
    • News Analysis
    • People Moves
    • Market Movers
    • Interviews
    • Professional Adviser TV
  • Your Business
    • Recruitment
    • Platforms
    • MPS
    • Education
    • Technology
    • Paraplanning
    • Diversity
    • Succession planning
  • Your Profession
    • Pensions
    • Investment
    • Regulation
    • ESG
    • Protection
    • Estate planning
    • Tax planning
    • Retirement
  • Consumer Duty
  • Events
  • About

    Authors

    • Jen Frost
    • Jenna Brown
    • Sahar Nazir
    • Isabel Baxter

    Featured Content

    • Cost of Living
    • Partner Insight
    • InvestmentIQ
    • PA360 Watchlist

    Sister publications

    • BusinessGreen
    • COVER
    • Investment Week
    • Professional Pensions

    Incisive Media

    • Our company
    • Careers
  • Searchlogo

    Search Professional Adviser

    x
Join Sign in
 
    • My account
    • Sign out
  • You are currently accessing Professional Adviser via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0) 1858 438800

    Email: [email protected]

    • Sign in
    • Sign in

News

PMI

Axa PPP extends cancer cover to rejected NHS drug

Axa PPP has extended its cancer coverage to include the clinically effective prostate cancer drug rejected for the NHS because it is too expensive.

clock 03 February 2012 •

Mortgages

SRB market shuts after FSA poor practice review

The FSA has temporarily shut the sale and rent back (SRB) market after a review found most transactions were either unaffordable or unsuitable and should not have been sold at all.

clock 03 February 2012 •

TCF

Banks slash bonuses as Miliband attacks pay - papers

Labour leader Ed Miliband will next week launch an attack on bonus culture in all sectors by calling for a Commons vote on the practice.

clock 03 February 2012 •

Offshore Investment

Barclays launches index-linked deposit account

Barclays Capital has launched a further UK Equity index-linked structured deposit account for offshore bond investors.

clock 03 February 2012 •

Offshore Investment

People on the move

Fairbairn Private Bank and Lombard International make new appointments.

clock 03 February 2012 •

Your profession

Spike in number of bank staff stealing from customers

The number of bank staff stealing or deceiving customers has risen by more than 40% in the last year, fraud figures show.

clock 02 February 2012 •

Income Protection

Govt set to bulldoze welfare reforms through Lords

The government looks set to force through its controversial welfare reforms without giving the House of Lords a chance to readdress the amendments it made.

clock 02 February 2012 •

PMI

Nice rejects 'clinically effective' cancer drug for being too expensive

Cancer charities have slammed the National Institute for Health and Clinical Excellence's (Nice) decision to reject a drug that prolongs the life of prostate cancer suffers for being too expensive.

clock 02 February 2012 •

Critical Illness

Brits still prefer pets to loved ones

Brits would rather insure pets than themselves or their families, a survey has found.

clock 02 February 2012 •

Regulation

Advisers' FSCS levy set at £33m

Advisers will contribute £33m towards the total expected cost of running the Financial Services Compensation Scheme (FSCS) in 2012/13, although they will also pay an additional interim levy of at least £40m before April.

clock 02 February 2012 •
274527462747
  • Contact Us
  • Marketing Solutions
  • About Incisive Media
  • Privacy Settings
  • Careers
  • Terms & Conditions
  • Policies
FOLLOW US
Incisive Media

© Incisive Business Media Limited, Published by Incisive Business Media Limited, New London House, 172 Drury Lane, London WC2B 5QR. Registered in England and Wales with company registration number 09178013. Part of Arc network, www.arc-network.com

DIGITAL PUBLISHER OF THE YEAR
right wallpaper ad
Loading.gif?page type=listing page&section=news